Off-label policy through the lens of trazodone usage and spending in the United States.

Health Aff Sch · 2025 · PMC12278056 · PMID 40692815

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Although on-label trazodone prescriptions are estimated to be reimbursed $1.95 less than off-label trazodone prescriptions, this difference also failed to reach statistical significance at the 5% or 10% levels.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.